業績一覧

HOME > 業績集 > 腎・高血圧グループ

腎・高血圧グループの業績一覧

Akiko Tanino, Takafumi Okura, Jun Irita, Tomoaki Nagao, Mie Kurata, Jun Suzuki, Masayoshi Kukida, Ken-ichi Miyoshi.

Neutralization of N-half Osteopontin Prevents Atherosclerotic Plaque Rupture in ApoE-/-Mice

J Cardio Vasc Med;2018 4: 1-10.

Kukida M, Mogi M, Kan-No H, Tsukuda K, Bai HY, Shan BS, Yamauchi T, Higaki

AT2 receptor stimulation inhibits phosphate-induced vascular calcification.

Kidney Int. 2018 Nov 5.

Ken-ichi Miyoshi, Takafumi Okura, Akiko Tanino, Masayoshi Kukida, Tomoaki Nagao, Jitsuo Higaki.

Usefulness of the renal resistive index to predict an increase in urinary albumin excretion in patients with essential hypertension.

J Hum Hypertens 2017;31:66-69.

Toshiyuki Chisaka*, Masaki Mogi*, Hirotomo Nakaoka*, Harumi Kan-no*, KanaTsukuda*,XL Wang*, HY Bai*,BS Shan*, Masayoshi Kukida, Jun Iwanami*,
Takashi Higaki*, Eiichi Ishii*, Masatsugu Horiuchi*.

Low-Protein Diet-Induced Fetal Growth Restriction Leads to Exaggerated Proliferative Response to Vascular Injury in Postnatal Life

Am J Hypertens 29:54-62, 2016.

Takao Saruta*, Toshio Ogihara*, Ikuo Saito*, Hiromi Rakugi*, Kazuaki Shimamoto*,
Hiroaki Matsuoka*, Satoshi Teramukai*, Jitsuo Higaki, Sadayoshi Ito*,
Kazuyuki Shimada*.

Comparison of Olmesartan Combined with a Calcium Channel Blocker or a Diuretic in Elderly Hypertensive Patients (COLM Study): Safety and Tolerability

Hypertens Res 38: 132-136, 2015.

Toshio Ogihara*, Takao Saruta*, Hiromi Rakugi*, Ikuo Saito*, Kazuaki Shimamoto*,
Hiroaki Matsuoka*, Satoshi Teramukai*, Jitsuo Higaki, Sadayoshi Ito*,
Kazuyuki Shimada*; COLM Investigators.

Combination Therapy of Hypertension in the Elderly: a Subgroup Analysis of the Combination of OLMesartan and a Calcium Channel Blocker or Diuretic in Japanese Elder Hypertensive Patients Trial

Hypertens Res 38: 89-96, 2015.

Hiromi Rakugi*, Toshio Ogihara*, Takao Saruta*, Tatsuo Kawai*, Ikuo Saito*,
Satoshi Teramukai*, Kazuyuki Shimada*, Shigehiro Katayama*, Jitsuo Higaji,
Masato Odawara*, Norio Tanahashi*, Genjiroh Kimura*; COLM Investigators.

Perferable Effects of Olmesartan /Calcium Channel Blocker to Olmesartan/Diuretic on Blood Pressure Variability in Very Elderly Hypertension: COLM Study Subanalysis

J Hypertens 33: 2165-2172, 2015.

HY Bai*, Masaki Mogi*, Hirotomo Nakaoka*, Harumi Kan-No*, Kana Tsukuda*,
Toshiyuki Chisaka*, XL Wang*, Masayoshi Kukida, BS Shan*, Toshifumi Yamauchi*,
Akinori Higaki, Jun Iwanami*, Mastsugu Horiuchi*.

Pre-treatment with LCZ696 an Orally Active Angiotensin Reseptor Neprilysin Inhibitor, Prevents Ischemic Brain Damage

Eur J Pharmacol 762: 293-298, 2015.

Kazuomi Kario*, Hisao Ogawa*, Ken Okumura*, Takafumi Okura, Shigeru Saito*,
Takafumi Ueno*, Russel Haskin*, Manuela Negoita*, Kazuyuki Shimada*, on behalf of the SYMPLICITY HTN-Japan Investigators.

SYMPLICITY HTN-Japan – First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients –

Circ J 79: 1222-1229, 2015.

Sachiko Onishi*, Endy Adnan*, Jun Ishizaki*, Tatsuhiko Miyazaki*, Yuki Tanaka*,
Takuya Matsumoto*, Koichiro Suemori*, Masachika Shudou*, Takafumi Okura,
Hiroyuki Takeda*, Tatsuya Sawasaki*, Masaki Yasukawa*, Hitoshi Hasegawa*.

Novel Autoantigens Associated with Lupus Nephritis

PLOS ONE 10: e 0126564, 2015.